FDA Inspection 1006380 — Carter BloodCare - Addison
The FDA completed an inspection of Carter BloodCare - Addison on April 4, 2017 in Addison, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 4, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Addison, TX (United States)